Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A.
暂无分享,去创建一个
Blossom Damania | Yuri Fedoriw | Dongmei Yang | Stephan Moll | D. Dittmer | B. Damania | J. Poisson | Charles van der Horst | D. Roy | Sang-Hoon Sin | C. M. van der Horst | Yuri Fedoriw | Dirk P Dittmer | K. Tamburro | Dongmei Yang | A. Lucas | N. Malouf | V. Moylan | S. Moll | Kristen M Tamburro | Jessica Poisson | Debasmita Roy | Amy Lucas | Sang-Hoon Sin | Nadia Malouf | Vincent Moylan | Y. Fedoriw
[1] S. Steinberg,et al. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] F. Kortüm,et al. Successful treatment of multicentric Castleman's disease with combined immunochemotherapy in an AIDS patient with multiorgan failure , 2008, Leukemia.
[3] É. Oksenhendler,et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. , 2000, Blood.
[4] N. Kamada,et al. Co-infection of HHV-6 and HHV-8 is rare in primary effusion lymphoma. , 2000, Leukemia research.
[5] G. Hayward,et al. Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] L. Hassman,et al. KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation. , 2011, The Journal of clinical investigation.
[7] K. Straif,et al. A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.
[8] Robert A. Greevy. Data Analysis and Graphics Using R: An Example-Based Approach , 2010 .
[9] I. Longden,et al. EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.
[10] D. Dittmer. Restricted Kaposi’s Sarcoma (KS) Herpesvirus Transcription in KS Lesions from Patients on Successful Antiretroviral Therapy , 2011, mBio.
[11] E. Ogawa,et al. Successful treatment of multicentric castleman's disease with bilateral orbital tumour using rituximab , 2003, British journal of haematology.
[12] Zan Huang,et al. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus. , 2005, The American journal of pathology.
[13] C. Boshoff,et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.
[14] D. Dittmer. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. , 2003, Cancer research.
[15] L. Medeiros,et al. Multicentric Castleman Disease , 2013 .
[16] A. Nienhuis,et al. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. , 1990, The Journal of clinical investigation.
[17] S. Lok,et al. Genomic Sequencing and Comparative Analysis of Epstein-Barr Virus Genome Isolated from Primary Nasopharyngeal Carcinoma Biopsy , 2012, PloS one.
[18] R. Talamini,et al. Plasma HHV‐8 viral load in HHV‐8‐related lymphoproliferative disorders associated with HIV infection , 2009, Journal of medical virology.
[19] N. Probst-Hensch,et al. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy , 2008, AIDS.
[20] R. Yarchoan,et al. Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome , 2012, Front. Microbio..
[21] H. Agut,et al. Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[22] S. Boudina,et al. Clinical manifestations of , 2009 .
[23] R. Tedder,et al. Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma? , 2011, International journal of STD & AIDS.
[24] S. Franceschi,et al. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy , 2008, British journal of cancer.
[25] Profiling of pre-micro RNAs and microRNAs using quantitative real-time PCR (qPCR) arrays. , 2010, Journal of visualized experiments : JoVE.
[26] E. Cesarman,et al. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV‐8)‐infected B cells in HIV+ multicentric Castleman disease (MCD) , 2008, Histopathology.
[27] J. Felsenstein,et al. Mathematics vs. Evolution: Mathematical Evolutionary Theory. , 1989, Science.
[28] John Maindonald,et al. Data Analysis and Graphics Using R: An Example-based Approach (Cambridge Series in Statistical and Probabilistic Mathematics) , 2003 .
[29] K. Zülch. Effects of Chemotherapy , 1986 .
[30] P. Pellett,et al. Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma , 2007, AIDS.
[31] E. Leproust,et al. Specific Capture and Whole-Genome Sequencing of Viruses from Clinical Samples , 2011, PloS one.
[32] J. Goudsmit,et al. Human Herpesvirus 8 Load in Matched Serum and Plasma Samples of Patients with AIDS-Associated Kaposi's Sarcoma , 2003, Journal of Clinical Microbiology.
[33] B. Chandran,et al. Activation of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Lytic Replication by Human Cytomegalovirus , 2001, Journal of Virology.
[34] Joseph Coco,et al. Detection of Murine Leukemia Virus in the Epstein-Barr Virus-Positive Human B-Cell Line JY, Using a Computational RNA-Seq-Based Exogenous Agent Detection Pipeline, PARSES , 2012, Journal of Virology.